Slate Path Capital LP
- SEC CIK
- 0001559706
- Latest filing
- Aug 14, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Slate Path Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −2,523,500−100.0% | Sold out | Holders |
| Q4 2025 | 2,523,500 | $167.5M | 2.3% | −2,458,500−49.3% | Reduced | Holders |
| Q3 2025 | 4,982,000 | $171.8M | 2.7% | −250,000−4.8% | Reduced | Holders |
| Q2 2025 | 5,232,000 | $82.7M | 1.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,232,000 | $66.7M | 1.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 5,232,000 | $98.4M | 1.8% | +347,000+7.1% | Added | Holders |
| Q3 2024 | 4,885,000 | $94.6M | 1.6% | +746,000+18.0% | Added | Holders |
| Q2 2024 | 4,139,000 | $107.6M | 2.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 4,139,000 | $118.4M | 2.3% | +2,810,000+211.4% | Added | Holders |
| Q4 2023 | 1,329,000 | $40.7M | 0.9% | +1,329,000 | New | Holders |